SO
About
Sotio is an international biotechnology company leading the efforts of PPF Group to build a diverse biotechnology portfolio through its own research & development, collaborations, in-licensing, investments, mergers, and acquisitions. The company is developing new medical therapies, focusing on the treatment of cancer and autoimmune diseases. The most advanced project is the SOTIO proprietary platform of active cellular immunotherapy (ACI) based on dendritic cells.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 386 investors are based in Prague, Hlavni mesto Praha, Czech Republic.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Prague, Czech Republic
Find more investors like Sotio
Search Investors